Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 109

1.

Uterine fibroids.

Stewart EA, Laughlin-Tommaso SK, Catherino WH, Lalitkumar S, Gupta D, Vollenhoven B.

Nat Rev Dis Primers. 2016 Jun 23;2:16043. doi: 10.1038/nrdp.2016.43.

PMID:
27335259
2.

Mifepristone inhibits extracellular matrix formation in uterine leiomyoma.

Patel A, Malik M, Britten J, Cox J, Catherino WH.

Fertil Steril. 2016 Apr;105(4):1102-10. doi: 10.1016/j.fertnstert.2015.12.021.

PMID:
26776909
3.

Possible involvement of inflammatory/reparative processes in the development of uterine fibroids.

Protic O, Toti P, Islam MS, Occhini R, Giannubilo SR, Catherino WH, Cinti S, Petraglia F, Ciavattini A, Castellucci M, Hinz B, Ciarmela P.

Cell Tissue Res. 2016 May;364(2):415-27. doi: 10.1007/s00441-015-2324-3.

PMID:
26613601
4.

Gynecologic health and disease in relation to the microbiome of the female reproductive tract.

Green KA, Zarek SM, Catherino WH.

Fertil Steril. 2015 Dec;104(6):1351-7. doi: 10.1016/j.fertnstert.2015.10.010. Review.

PMID:
26597627
5.

Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones.

Malik M, Britten J, Cox J, Patel A, Catherino WH.

Fertil Steril. 2016 Jan;105(1):214-24. doi: 10.1016/j.fertnstert.2015.09.006.

PMID:
26409322
6.

Prevalence, morbidity, and current medical management of uterine leiomyomas.

Drayer SM, Catherino WH.

Int J Gynaecol Obstet. 2015 Nov;131(2):117-22. doi: 10.1016/j.ijgo.2015.04.051. Review.

PMID:
26275638
7.

Alternative therapies in management of leiomyomas.

Patel A, Malik M, Britten J, Cox J, Catherino WH.

Fertil Steril. 2014 Sep;102(3):649-55. doi: 10.1016/j.fertnstert.2014.07.008. Review.

PMID:
25106764
8.

Leiomyoma cells in 3-dimensional cultures demonstrate an attenuated response to fasudil, a rho-kinase inhibitor, when compared to 2-dimensional cultures.

Malik M, Britten J, Segars J, Catherino WH.

Reprod Sci. 2014 Sep;21(9):1126-38. doi: 10.1177/1933719114545240.

9.

Recommended practices for the management of embryology, andrology, and endocrinology laboratories: a committee opinion.

Practice Committee of the American Society for Reproductive Medicine.; Practice Committee of the Society for Assisted Reproductive Technology.; Practice Committee of the Society of Reproductive Biologists and Technologists..

Fertil Steril. 2014 Oct;102(4):960-3. doi: 10.1016/j.fertnstert.2014.06.036. Review.

PMID:
25064400
10.

Repetitive oocyte donation: a committee opinion.

Practice Committee of the American Society for Reproductive Medicine.; Practice Committee of the Society for Assisted Reproductive Technology..

Fertil Steril. 2014 Oct;102(4):964-6. doi: 10.1016/j.fertnstert.2014.06.035.

PMID:
25064399
11.

Revised minimum standards for practices offering assisted reproductive technologies: a committee opinion.

Practice Committee of the American Society for Reproductive Medicine.; Practice Committee of the Society for Assisted Reproductive Technology.; Practice Committee of the Society of Reproductive Biology and Technology..

Fertil Steril. 2014 Sep;102(3):682-6. doi: 10.1016/j.fertnstert.2014.05.035.

PMID:
24954775
12.

Role of assisted hatching in in vitro fertilization: a guideline.

Practice Committee of the American Society for Reproductive Medicine.; Practice Committee of the Society for Assisted Reproductive Technology..

Fertil Steril. 2014 Aug;102(2):348-51. doi: 10.1016/j.fertnstert.2014.05.034. Review.

PMID:
24951365
13.

Tranilast, an orally active antiallergic compound, inhibits extracellular matrix production in human uterine leiomyoma and myometrial cells.

Islam MS, Protic O, Ciavattini A, Giannubilo SR, Tranquilli AL, Catherino WH, Castellucci M, Ciarmela P.

Fertil Steril. 2014 Aug;102(2):597-606. doi: 10.1016/j.fertnstert.2014.05.013.

PMID:
24934492
14.

Liarozole inhibits transforming growth factor-β3--mediated extracellular matrix formation in human three-dimensional leiomyoma cultures.

Levy G, Malik M, Britten J, Gilden M, Segars J, Catherino WH.

Fertil Steril. 2014 Jul;102(1):272-281.e2. doi: 10.1016/j.fertnstert.2014.03.042.

15.

Ovarian tissue cryopreservation: a committee opinion.

Practice Committee of American Society for Reproductive Medicine..

Fertil Steril. 2014 May;101(5):1237-43. doi: 10.1016/j.fertnstert.2014.02.052. Review.

PMID:
24684955
16.

Treatment of pelvic pain associated with endometriosis: a committee opinion.

Practice Committee of the American Society for Reproductive Medicine..

Fertil Steril. 2014 Apr;101(4):927-35. doi: 10.1016/j.fertnstert.2014.02.012. Erratum in: Fertil Steril. 2015 Aug;104(2):498.

PMID:
24630080
17.

Role of activin-A and myostatin and their signaling pathway in human myometrial and leiomyoma cell function.

Islam MS, Catherino WH, Protic O, Janjusevic M, Gray PC, Giannubilo SR, Ciavattini A, Lamanna P, Tranquilli AL, Petraglia F, Castellucci M, Ciarmela P.

J Clin Endocrinol Metab. 2014 May;99(5):E775-85. doi: 10.1210/jc.2013-2623.

18.

Impact of surgical approach on blood loss during intracapsular myomectomy.

Tinelli A, Mettler L, Malvasi A, Hurst B, Catherino W, Mynbaev OA, Guido M, Alkatout I, Schollmeyer T.

Minim Invasive Ther Allied Technol. 2014 Mar;23(2):87-95. doi: 10.3109/13645706.2013.839951.

PMID:
24044380
19.

Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion.

Practice Committee of American Society for Reproductive Medicine..

Fertil Steril. 2013 Nov;100(5):1214-23. doi: 10.1016/j.fertnstert.2013.08.012.

PMID:
24011612
20.

Optimizing natural fertility: a committee opinion.

Practice Committee of American Society for Reproductive Medicine in collaboration with Society for Reproductive Endocrinology and Infertility..

Fertil Steril. 2013 Sep;100(3):631-7. doi: 10.1016/j.fertnstert.2013.07.011.

PMID:
23993665
Items per page

Supplemental Content

Loading ...
Support Center